Cart (0 Items)
Your cart is currently empty.
View Products-
-
-
Icrucumab Biosimilar – Anti-FLT1, VEGFR-1 mAb – Research Grade
| Size | 100ug, 1MG |
|---|---|
| Isotype | IgG1, kappa |
| Brand | ProteoGenix |
| Product type | Primary Antibodies |
| Clonality | Monoclonal Antibody |
| Expression system | Mammalian cells |
| Applications | Elisa, WB |
| Product name | Icrucumab Biosimilar - Anti-FLT1, VEGFR-1 mAb - Research Grade |
|---|---|
| Source | CAS 1024603-92-6 |
| Species | Homo sapiens |
| Purity | >85% |
| Buffer | PBS buffer PH7.5 |
| Delivery condition | Blue ice (+4°C) |
| Delivery Time | 3-5 days if in stock; 3-5 weeks if production needed |
| Storage condition | store at -80°C |
| Brand | ProteoGenix |
| Aliases /Synonyms | Icrucumab,18F1,IMC-18F1,LY3012212,FLT1, VEGFR-1,anti-FLT1, VEGFR-1 |
| Reference | PX-TA1257 |
| Note | For research use only. Not suitable for clinical or therapeutic use. |
| Isotype | IgG1-kappa |
| Clonality | Monoclonal Antibody |
Description of Icrucumab Biosimilar - Anti-FLT1, VEGFR-1 mAb - Research Grade
General information on Anti-FLT1/ VEGFR-1[Homo sapiens] (Icrucumab) Monoclonal Antibody
Icrucumab is investigated for the treatment of Colorectal Cancer.
Icrucumab Biosimilar - Anti-FLT1, VEGFR-1 mAb binds to Human FLT1 recombinant protein in indirect ELISA Assay
Immobilized Human FLT1 recombinant protein (cat. No.PX-P6096) at 0.5µg/mL (100µL/well) can bind to Icrucumab Biosimilar - Anti-FLT1, VEGFR-1 mAb (cat. No.PX-TA1257) in indirect ELISA with Goat Anti-Human IgG secondary antibody coupled with HRP measured by OD450
Related products
Antigen
EGFR protein – Epidermal growth factor receptor(EGFR)
PX-P4586 250$
Isotype Control
Human IgG1 LALA Isotype Control antibody (HyHEL-10)
PTX17885 215$
ELISA
Icrucumab ELISA Kit
KPTX201 1404$Contact us
Send us a message from the form below
Reviews
There are no reviews yet.